by Usha Govindarajulu | Oct 9, 2024 | Biostatistics, Epidemiology, Healtcare, Usha Govindarajulu
Statistical issues in survival analysis (Part XVVVVV) October 9, 2024 The authors have discussed some issues in survival analysis in relation to Kaplan-Meier curves. They then came up with alternative ways to design, analyze, and interpret the results of the trials...
by Usha Govindarajulu | Aug 16, 2023 | Biostatistics, Blog, COVID-19, Epidemiology, Healtcare, Usha Govindarajulu
The authors developed a proportional incidence model to estimate vaccine effectiveness (VE) but at the population level. Understanding VE during the COVID-19 pandemic was very important. Since obtaining individual level data linkages, the authors used aggregated...
by Usha Govindarajulu | Apr 26, 2023 | Biostatistics, Blog, COVID-19, Epidemiology, Healtcare, Usha Govindarajulu
April 26, 2023 In a recent article that appeared in Statistics in Medicine, Arntzen et al discussed that quarantine time length for persons infected with SARS-CoV-2 was based on incubation time distribution estimates. However, given the unknowns about time to...
by Usha Govindarajulu | Mar 16, 2023 | Biostatistics, Blog, COVID-19, Healtcare, Machine Learning, Usha Govindarajulu
March 15, 2023 In a recent article that appeared in Science News, a teach from Johns Hopkins University discussed their proof of concept study to show how their machine learning system used electronic health data to make predictions to determine who would be most...
by Usha Govindarajulu | Dec 21, 2022 | Biostatistics, Blog, COVID-19, Epidemiology, Healtcare, Usha Govindarajulu
December 21, 2022 In an article published on December 14, 2022 in MSN.com, researchers had been studying the effect of COVID-19 and exercise and had found a strong correlation or link between the disease and exercise according to research cited from an article...
by Usha Govindarajulu | Dec 8, 2022 | Biostatistics, Blog, COVID-19, Healtcare, Usha Govindarajulu
December 5, 2022 A recent article that appeared December 1 in JAMA Open Network shows the retrospective analysis of Remdesivir treatment for inpatient mortality among COVID-19 patients using insurance claims data amongst 24,856 adults hospitalized between May 1, 2020...
